Success Metrics

Clinical Success Rate

75.0%

Based on 6 completed trials

Completion Rate

75%(6/8)

Active Trials

1(11%)

Results Posted

33%(2 trials)

Terminated

2(22%)

Phase Distribution

Ph phase_2

67%

Ph phase_3

22%

Ph phase_1

11%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

1(11.1%)

Phase 2Efficacy & side effects

6(66.7%)

Phase 3Large-scale testing

2(22.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(6)

Terminated(2)

Detailed Status

Completed6

Terminated2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (11.1%)

Phase 26 (66.7%)

Phase 32 (22.2%)

Trials by Status

completed667%

recruiting111%

terminated222%

Recent Activity

1 active trials

Showing 5 of 9

recruitingphase_3

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

NCT01954992

completedphase_2

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

NCT00441467

terminatedphase_2

Safety and Efficacy Study of Glufosfamide in Ovarian Cancer

NCT00442598

completedphase_2

Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer

NCT00005053

completedphase_2

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00014300

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT01954992Phase 3

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Recruiting

NCT00441467Phase 2

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Completed

NCT00442598Phase 2

Safety and Efficacy Study of Glufosfamide in Ovarian Cancer

Terminated

NCT00005053Phase 2

Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer

Completed

NCT00014300Phase 2

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

Completed

NCT00005055Phase 2

Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer

Completed

NCT00435578Phase 2

Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma

Terminated

NCT00102752Phase 1

Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

Completed

NCT00099294Phase 3

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

Completed

All 9 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 9